{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-125071","form_type":"8-K","ticker":"TEVA","cik":"0000818686","company_name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.389940+00:00","generated_at":"2026-05-20T19:45:38.853351+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Teva prices $2.3B multi-tranche senior notes offering to refinance existing debt","bullets":["Upsized offering from $2B to ~$2.3B equivalent across three tranches.","€1B 4.125% due 2031 (priced 99.349%), $500M 6.000% due 2032 (99.256%), $700M 5.750% due 2030 (99.418%).","Settlement expected May 28, 2025, subject to customary closing conditions.","Proceeds to fund tender offers for existing notes with coupons 3.15%-8.125% maturing 2026-2031.","Net proceeds may also be used for debt repayment at maturity, tender, or redemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-125071","json":"https://secwatch.observer/filing/0001193125-25-125071.json","markdown":"https://secwatch.observer/filing/0001193125-25-125071.md","text":"https://secwatch.observer/filing/0001193125-25-125071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818686/000119312525125071/0001193125-25-125071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818686/000119312525125071/d929611d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T19:45:38.853351+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}